SEC Form 5 · accession 0001562180-17-000613
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P. Butler
Officer — CEO and President · Director
Period of report
Dec 31, 2016
Accepted (ET)
Feb 10, 2017 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001517022
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 28, 2016 | G | 116,800 | $0.00 | D | 198,280 | D | |
| Common StockF2 | Jul 28, 2016 | G | 58,400 | $0.00 | A | 58,400 | I | GRAT - Spouse |
| Common StockF3 | holding | — | — | — | 58,400 | I | GRAT |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On July 28, 2016, the reporting person made the following transfers for estate planning purposes: 58,400 shares were transferred to the Dorothy Butler 2016 GRAT, 29,200 shares were transferred to the Dorothy Butler 2016 Irrevocable Trust, and 29,200 shares were transferred to the John P. Butler 2016 Irrevocable Trust.
- F2Of the shares tranferred by the reporting person on July 28, 2016, 58,400 were contributed to the Dorothy Butler 2016 GRAT, of which the reporting person's wife serves as trustee.
- F3These shares were previously reported as directly beneficially owned, but were contributed to the John Butler 2016 GRAT on July 28, 2016.